Heterogeneity within the PF-EPN-B ependymoma subgroup

Area of Science:

• Neuro-oncology
• Genomics
• Molecular Pathology

Background:

• Posterior fossa ependymoma (PF-EPN-B) is a distinct molecular variant of ependymoma.
• Understanding PF-EPN-B heterogeneity is vital, especially for potential radiation avoidance trials.

Purpose of the Study:

• To investigate the molecular heterogeneity within posterior fossa ependymoma type B (PF-EPN-B) tumors.
• To identify distinct molecular subtypes and their clinical correlations.

Main Methods:

• Integrated analysis of DNA methylation, copy-number profiling, and gene expression.
• Analysis of 212 primary posterior fossa PF-EPN-B tumors.
• Unsupervised clustering (spectral clustering, t-SNE) of methylation data.

Main Results:

• Five distinct molecular subtypes (PFB1-5) were identified within PF-EPN-B.
• Subtypes exhibit unique demographics, copy-number alterations, and gene expression profiles.
• Chromosome 13q loss identified as a potential novel marker for risk stratification.

Conclusions:

• PF-EPN-B tumors display significant intertumoral heterogeneity, similar to PF-EPN-A.
• Extent of resection remains the primary predictor of outcome, despite molecular subtypes.
• Identified heterogeneity necessitates consideration in future preclinical models and personalized ependymoma therapies.